Bartolini M.; Andrisano V., FAST vs IN-DEPTH CHARACTERIZATION OF NEW CHOLINESTERASES
INHIBITORS BY IMMOBILIZED ENZYME REACTORS, in: 10th International Meeting on Cholinesterases, PROGRAMME AND ABSTRACTS, ZAGREB, Zrinka Kovarik, 2009, pp. 74 - 74 (atti di: 10th International Meeting on Cholinesterases, Šibenik, Croatia, 20-25 September 2009) [Contribution to conference proceedings]
Coordination of a Research Project: FP7 reasearch project ‘BISNES: Bio-Inspired Self-assembled Nano-Enabled Surfaces' in the call NMP-2007-1.1-1 “Nano-scale mechanisms of bio/non-bio interactions” NMP-2007-1.1-2 “Self-assembling and self-organisation”. grant agreement number: 214538..
Marina Naldi; Natalia Calonghi; Lanfranco Masotti; Carola Parolin; Sergio Valente; Antonello Mai; Vincenza Andrisano, Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors, «PROTEOMICS», 2009, 9, pp. 5437 - 5445 [Scientific article]
D. Muñoz-Torrero; P. Camps; X. Formosa; C. Galdeano; E. Viayna; A. Badia; M. Victòria Clos; M. Pera; M. Ratia; B. Pérez Fernández; M. Bartolini; F. Mancini; V. Andrisano; G. C. González-Muñoz; M. I. Rodríguez-Franco; L. Rivail; F. J. Luque, HUPRINETACRINE HYBRIDS AS A NOVEL FAMILY OF MULTI-TARGET DRUG CANDIDATES AGAINST ALZHEIMER’S AND PRION DISEASES, in: 10th International Meeting on Cholinesterases, Programme and Abstracts, ZAGREB, ZRINKA KOVARIK, 2009, pp. 75 - 75 (atti di: 10th International Meeting on Cholinesterases, Šibenik, Croatia, 20-25 September 2009) [Contribution to conference proceedings]
Bartolini M.; Greig N.H.; Yu Q.S.; Andrisano V., Immobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer's disease., «JOURNAL OF CHROMATOGRAPHY A», 2009, 1216, pp. 2730 - 2738 [Scientific article]
M. Bartolini; V. Andrisano, IMMOBILIZED ENZYME REACTORS INTO THE DRUG DISCOVERY PROCESS: THE ALZHEIMER’S DISEASE CASE, in: Nuove Prospettive in Chimica Farmaceutica - III meeting workshop - ATTI, s.l, s.n, 2009, pp. 93 - 93 (atti di: III NPCF3 – Nuove Prospettive in Chimica Farmaceutica, Castelvecchio Pascoli (LU), Italia, 13-14 Febbraio 2009) [Contribution to conference proceedings]
Mancini F.; Bolognesi M.L.; Melchiorre C.; Andrisano V., Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of
Alzheimer's disease., «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2009, 50(2), pp. 164 - 170 [Scientific article]
F. Mancini; C. Cavallari; P. Filippi; L. Rodriguez; A. M. Di Pietra; V. Andrisano, LC analysis of Oxytetracycline and Chlortetracycline: application for in vitro bio-equivalence study of veterinary medicines, «CHROMATOGRAPHIA», 2009, 69 (3/4), pp. 215 - 220 [Scientific article]
Bolognesi M.L.; Rosini M.; Andrisano V.; Bartolini M.; Minarini A.; Tumiatti V.; Melchiorre C., MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond, «CURRENT PHARMACEUTICAL DESIGN», 2009, 15, pp. 601 - 613 [Scientific article]
M. Rosini; M. Bartolini; E. Simoni; C. Gotti; D. McClymont; ML Bolognesi; A. Minarini; V. Tumiatti; V. Andrisano; I. R. Mellor; C. Melchiorre, Multi-Target-Direcetd Ligands as acetylcholinesterase inhibitors and nicotinic modulators for Alzheimer's disease, in: , «DRUGS OF THE FUTURE», 2009, 34, pp. 195 - 195 (atti di: Frontiers in medicinal chemistry: Emerging targets, novel candidates and innovative strategies, Barcelona, October, 4-6, 2009) [Abstract]
E. Viayna; P. Camps; X. Formosa; C. Galdeano; T. Gómez; D. Muñoz-Torrero; M. Scarpellini; A. Badia; M. V. Clos; A. Camins; M. Pallàs; M. Bartolini; F. Mancini; V. Andrisano; J. Estelrich; M. Lizondo; A. Bidon-Chanal; F. J. Luque, NOVEL DONEPEZIL-BASED INHIBITORS OF CHOLINESTERASES AND ACETYLCHOLINESTERASE-INDUCED BETA-AMYLOID AGGREGATION, in: , «DRUGS OF THE FUTURE», 2009, 34, Suppl. A, pp. 59 - 59 (atti di: Frontiers in medicinal chemistry: Emerging targets, novel candidates and innovative strategies., Barcelona, Spain, October 4-6, 2009) [Abstract]
Patent n. US 7,589,219 B2, Preparation of 2,5-bis-diamine-[1,4]benzoquinone derivatives for the treatment of Alzheimer's disease and a process for their preparation and intermediates thereof..
M. Naldi; N. Calonghi; L. Masotti; C. Parolin; V. Andrisano, PROTEOMIC ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF HUMAN HISTONES IN CANCER DRUG DISCOVERY, in: Recent Development in Pharmaceutical Analysis Abstract Book, s.l, s.n, 2009, pp. 46 - 46 (atti di: RDPA 2009, Milano, 9-12 Settembre 2009) [Abstract]
Camps P.; Formosa X.; Galdeano C.; Muñoz-Torrero D.; Ramírez L.; Gómez E.; Isambert N.; Lavilla R.; Badia A.; Clos M.V.; Bartolini M.; Mancini F.; Andrisano V.; Arce M.P.; Rodríguez-Franco M.I.; Huertas O.; Dafni T.; Luque F.J., Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds, «JOURNAL OF MEDICINAL CHEMISTRY», 2009, 52, pp. 5365 - 5379 [Scientific article]
M. Naldi; E. Vasina; S. Dobroiu; L. Paraoan; D.V. Nicolau; V. Andrisano, Self-assembly of biomolecules: AFM study of F-actin on unstructured and nanostructured surfaces, in: Progress in Biomedical Optics and Imaging - Proceedings of SPIE, s.l, s.n, 2009, 7188-71880Q, pp. 1 - 6 (atti di: Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications VI;, San Jose, CA;, 27- 28 January 2009) [Contribution to conference proceedings]
